Amiodarone-Induced Lung Toxicity: A Case Initially Not Correctly Framed

Area of Science:

• Pulmonology
• Pharmacology
• Toxicology

Background:

• Amiodarone-induced pulmonary toxicity (AIPT) is a severe adverse effect of amiodarone, a common antiarrhythmic drug.
• Risk factors include dosage, patient age, and pre-existing lung conditions, with toxicity often linked to cumulative doses exceeding 150 mg.
• The exact mechanisms of AIPT's etiology and pathogenesis remain unclear, necessitating further research.

Observation:

• A case report details a female patient experiencing amiodarone-induced pulmonary toxicity from a prolonged overdose (200 mg/day for two years).
• The patient presented with respiratory symptoms and instrumental evidence of amiodarone drug toxicity.
• Diagnosis was based on clinical and laboratory data, without invasive procedures like bronchoalveolar lavage or transbronchial biopsy.

Findings:

• Treatment with oral prednisone (starting at 50 mg/day, gradually tapered) led to significant improvement in the patient's condition.
• Computed tomography scans post-treatment showed resolution of ground-glass opacities and reduced bi-apical pulmonary fibrosis.
• This case highlights successful management of AIPT in a female patient, a demographic less commonly affected.

Implications:

• Corticosteroid therapy, particularly prednisone, appears effective in managing amiodarone-induced pulmonary toxicity, even in cases without invasive diagnostic confirmation.
• This case underscores the importance of considering AIPT in patients with relevant exposure history and respiratory symptoms.
• Further investigation into AIPT's pathogenesis and optimal treatment strategies, including the role of steroids, is warranted.